| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Magdalena Świądro-Piętoń, Dominika Dudek, Renata Wietecha-Posłuszn. Direct Immersion-Solid Phase Microextraction for Therapeutic Drug Monitoring of Patients with Mood Disorders. Molecules (Basel, Switzerland). vol 29. issue 3. 2024-02-10. PMID:38338419. |
it has been adapted to identify the most commonly used drugs in mood disorders, including amitriptyline, citalopram, fluoxetine, paroxetine, sertraline, trazodone, duloxetine, venlafaxine, lamotrigine, quetiapine, olanzapine, and mirtazapine. |
2024-02-10 |
2024-02-12 |
Not clear |
| Nitasha Agrawal, Sergio Marco-Peiró, Josep Esteve-Romero, Abhilasha Durgbanshi, Devasish Bose, Juan Peris-Vicente, Samuel Carda-Broc. Determination of paroxetine in blood and urine using micellar liquid chromatography with electrochemical detection. Journal of chromatographic science. vol 52. issue 10. 2015-07-02. PMID:24448669. |
paroxetine is a potent selective serotonin reuptake inhibitor used for the treatment of depression and related mood disorders. |
2015-07-02 |
2023-08-12 |
human |
| F Arias, J J Padín, I Gilaberte, P Varillas, R Sánchez, S Gómez, D Garcí. Comparative efficacy and tolerability among different selective serotonin re-uptake inhibitors and venlafaxine in a naturalistic setting. International journal of psychiatry in clinical practice. vol 2. issue 4. 2014-06-17. PMID:24927088. |
the sample was composed of 194 patients with mood disorders (major depressive disorder or dysthymic disorder according to the dsm-tv criteria) who began treatment either with an ssri (fluoxetine, fluvoxamine, paroxetine, sertraline, and citalopram) or with venlafaxine. |
2014-06-17 |
2023-08-13 |
Not clear |
| Masaki Kato, Raffaella Zanardi, David Rossini, Diana De Ronchi, Gaku Okugawa, Toshihiko Kinoshita, Cristina Colombo, Alessandro Serrett. 5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients. Psychiatry research. vol 167. issue 1-2. 2009-06-10. PMID:19361869. |
the sample comprised 203 patients affected by mood disorders and treated for major depression with paroxetine or fluvoxamine. |
2009-06-10 |
2023-08-12 |
Not clear |
| P Paruchuri, D Godkar, D Anandacoomarswamy, K Sheth, S Niranja. Rare case of serotonin syndrome with therapeutic doses of paroxetine. American journal of therapeutics. vol 13. issue 6. 2007-02-09. PMID:17122538. |
paroxetine (paxil) is a selective serotonin reuptake inhibitor (ssri) and anxiolytic that is approved to treat numerous mood disorders. |
2007-02-09 |
2023-08-12 |
Not clear |
| Kimberly A Yonker. Paroxetine treatment of mood disorders in women: premenstrual dysphoric disorder and hot flashes. Psychopharmacology bulletin. vol 37 Suppl 1. 2004-01-28. PMID:14566208. |
paroxetine treatment of mood disorders in women: premenstrual dysphoric disorder and hot flashes. |
2004-01-28 |
2023-08-12 |
Not clear |
| D Arnone, L Hansen, J S Ker. Acute dystonic reaction in an elderly patient with mood disorder after titration of paroxetine: possible mechanisms and implications for clinical care. Journal of psychopharmacology (Oxford, England). vol 16. issue 4. 2003-05-19. PMID:12503843. |
acute dystonic reaction in an elderly patient with mood disorder after titration of paroxetine: possible mechanisms and implications for clinical care. |
2003-05-19 |
2023-08-12 |
Not clear |